The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions

por Gomaa, Adel A., Abdel-Wadood, Yasmin A.
Publicado 2021

Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment

por Gomaa, Adel A., Abdel-Wadood, Yasmin A., Gomaa, Mohamed A.
Publicado 2022

Boswellic acids/Boswelliaserrata extract as a potential COVID-19 therapeutic agent in the elderly

por Gomaa, Adel A., Mohamed, Hamdy S., Abd-ellatief, Rasha Bakheet, Gomaa, Mohamed A.
Publicado 2021

Vitamin D: an essential adjuvant therapeutic agent in breast cancer

por Thabet, Romany H, Gomaa, Adel A, Matalqah, Laila M, Shalaby, Erin M
Publicado 2022

Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial

por Gomaa, Adel A., Mohamed, Hamdy S., Abd-ellatief, Rasha B., Gomaa, Mohamed A., Hammam, Doaa S.
Publicado 2022

Retraction Note: Polyphenols from Conyza dioscoridis (L.) ameliorate Alzheimer’s disease- like alterations through multi-targeting activities in two animal models

por Gomaa, Adel A., Farghaly, Hanan S. M., Makboul, Rania M., Hussien, Abeer M., Nicola, Mariam A.
Publicado 2023

Polyphenols from Conyza dioscoridis (L.) ameliorate Alzheimer’s disease- like alterations through multi-targeting activities in two animal models

por Gomaa, Adel A., Farghaly, Hanan S. M., Makboul, Rania M., Hussien, Abeer M., Nicola, Mariam A.
Publicado 2022